Literature DB >> 15090824

Care of patients with hepatitis C and HIV co-infection.

Vincent Soriano, Massimo Puoti, Mark Sulkowski, Stefan Mauss, Patrice Cacoub, Antonietta Cargnel, Douglas Dieterich, Angelos Hatzakis, Jurgen Rockstroh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15090824     DOI： 10.1097/00002030-200401020-00001

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  26 in total

Review 1.  Evaluation and treatment of hepatitis C in patients with coexisting HIV infection.

Authors:  Scott D Parker
Journal:  MedGenMed       Date:  2006-09-05

2.  Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China.

Authors:  Han-Zhu Qian; Sten H Vermund; Richard A Kaslow; Christopher S Coffey; Eric Chamot; Zhongmin Yang; Xiaochun Qiao; Yuliang Zhang; Xiaoming Shi; Yan Jiang; Yiming Shao; Ning Wang
Journal:  AIDS       Date:  2006-06-26       Impact factor: 4.177

3.  Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.

Authors:  María J Pérez-Elías; María Larrousse Morellon; Enrique Ortega; José Hernández-Quero; Maribel Rodríguez-Torres; Bonaventura Clotet; Franco Felizarta; Felix Gutiérrez; Juan A Pineda; Garrett Nichols; Yu Lou; Mary Beth Wire
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

4.  Management of Hepatitis C in HIV-infected Patients.

Authors:  Benigno Rodriguez; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

5.  Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients.

Authors:  Valerianna K Amorosa; Omowunmi Aibana; Norah J Shire; Zachariah Dorey-Stein; Thomas Ferrara; Joanne Gilmore; Jay R Kostman; Vincent Lo Re
Journal:  J Clin Gastroenterol       Date:  2013 May-Jun       Impact factor: 3.062

6.  Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.

Authors:  Monica A Konerman; Shruti H Mehta; Catherine G Sutcliffe; Trang Vu; Yvonne Higgins; Michael S Torbenson; Richard D Moore; David L Thomas; Mark S Sulkowski
Journal:  Hepatology       Date:  2014-01-16       Impact factor: 17.425

7.  Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³.

Authors:  Constanza Lucero; Berta Torres; Agathe León; Marta Calvo; Lorna Leal; Iñaki Pérez; Montserrat Plana; Mireia Arnedo; Josep Mallolas; Josep M Gatell; Felipe García
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-18       Impact factor: 2.205

8.  Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients.

Authors:  Laure Valerio; Yazdan Yazdanpanah; Isabelle Poizot-Martin; Eric Rosenthal; Catherine Marimoutou; Jean-Albert Gastaut; Albert Tran; Pierre Dellamonica; Kenneth A Freedberg; Christian Pradier
Journal:  J Acquir Immune Defic Syndr       Date:  2008-01-01       Impact factor: 3.731

9.  HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey.

Authors:  Kostyantyn V Dumchev; Ruslan Soldyshev; Han-Zhu Qian; Olexandr O Zezyulin; Susan D Chandler; Pavel Slobodyanyuk; Larisa Moroz; Joseph E Schumacher
Journal:  Harm Reduct J       Date:  2009-08-23

10.  Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil.

Authors:  Zelma B Costa; Gustavo C Machado; Mariza M Avelino; Clidenor Gomes Filho; Jose V Macedo Filho; Ana L Minuzzi; Marilia D Turchi; Mariane M A Stefani; Wayner Vieira de Souza; Celina Mt Martelli
Journal:  BMC Infect Dis       Date:  2009-07-27       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.